1 | 78859-46-8 | cairomycin A | cairomycin A | C9H14N2O4
| | |
2 | | AURORA KA-399 | AURORA KA-399 | C9H14N2O4
| | |
3 | 206757-32-6 | 掌叶半夏碱戊 | Pedatisectine F | C9H14N2O4
| 生物碱;分析试剂标准品;标准品 -中药标准品 | |
4 | 184685-17-4 | Boc-β-cyano-D-Ala-OH | Boc-β-cyano-D-Ala-OH | C9H14N2O4
| | |
5 | 187226-83-1 | 奥司他韦杂质15 | Oseltamivir Impurity 15 | C9H14N2O4
| | |
6 | 45159-34-0 | Boc-beta-氰基-L-丙氨酸 | Boc-beta-cyano-l-alanine | C9H14N2O4
| 氨基酸衍生化合物 | |
7 | | BOC-BETA-CYANO-DL-ALANINE | BOC-BETA-CYANO-DL-ALANINE | C9H14N2O4
| | |
8 | | N-(N-Acetyl-L-prolyl)glycine | N-(N-Acetyl-L-prolyl)glycine | C9H14N2O4
| | |
9 | | 1-(3,5-Dihydroxypentyl)uracil | 1-(3,5-Dihydroxypentyl)uracil | C9H14N2O4
| | |
10 | 66941-27-3 | 5-(Ethoxymethyl)-5-ethylbarbituric acid | 5-(Ethoxymethyl)-5-ethylbarbituric acid | C9H14N2O4
| | |
11 | 13440-26-1 | 2-METHYL-5-ARABOTETRAHYDROXYBUTYLPYRAZINE | 2-METHYL-5-ARABOTETRAHYDROXYBUTYLPYRAZINE | C9H14N2O4
| | |
12 | 926237-98-1 | 5-氧代-5-(3-氧代哌嗪-1-基)戊酸 | 5-oxo-5-(3-oxopiperazin-1-yl)pentanoic acid | C9H14N2O4
| | |
13 | 501127-89-5 | 3,5-二氧代哌嗪-1-羧酸叔丁酯 | tert-butyl 3,5-dioxopiperazine-1-carboxylate | C9H14N2O4
| | |
14 | 397244-77-8 | 4-氧-4-(5-氧-1,4-二氮杂-1-基)丁酸 | 4-OXO-4-(5-OXO-1,4-DIAZEPAN-1-YL)BUTANOICACID | C9H14N2O4
| | |
15 | 28711-05-9 | N,N'-methylenebis[N-(hydroxymethyl)acrylamide] | N,N'-methylenebis[N-(hydroxymethyl)acrylamide] | C9H14N2O4
| | |
16 | | 4-[(butylcarbamoyl)amino]-4-oxobut-2-enoic acid | 4-[(butylcarbamoyl)amino]-4-oxobut-2-enoic acid | C9H14N2O4
| | |
17 | 163929-77-9 | (R)-(2,5-二氧代吡咯烷-3-基)氨基甲酸叔丁酯 | (R)-tert-butyl 2,5-dioxopyrrolidin-3-ylcarbamate | C9H14N2O4
| | |
18 | 610311-91-6 | 3-(4-乙基-2,3-二氧代-哌嗪-1-基)丙酸 | 1-Piperazinepropanoicacid,4-ethyl-2,3-dioxo-(9CI) | C9H14N2O4
| | |
19 | 2155-62-6 | butan-2-yl (Z)-3-(carbamoylcarbamoyl)prop-2-enoate | butan-2-yl (Z)-3-(carbamoylcarbamoyl)prop-2-enoate | C9H14N2O4
| | |
20 | 1086380-62-2 | 1-Morpholin-4-yl-5-oxopyrrolidine-3-carboxylic acid | 1-Morpholin-4-yl-5-oxopyrrolidine-3-carboxylic acid | C9H14N2O4
| | |
21 | 1379812-12-0 | 3-(硝基亚甲基)氮杂环丁烷-1-羧酸叔丁酯 | tert-Butyl 3-(nitromethylene)azetidine-1-carboxylate | C9H14N2O4
| | |
22 | 124842-29-1 | (S)-(2,5-二氧代吡咯烷-3-基)氨基甲酸叔丁酯 | tert-butyl N-[(3S)-2,5-dioxopyrrolidin-3-yl]carbamate | C9H14N2O4
| | |
23 | | 2-AMINO-5-OXO-5-(5-OXO-PYRROLIDIN-2-YL)-PENTANOIC ACID | 2-AMINO-5-OXO-5-(5-OXO-PYRROLIDIN-2-YL)-PENTANOIC ACID | C9H14N2O4
| | |
24 | 1418117-73-3 | 3-(2,5-二氧代-4-甲基-4-咪唑烷基)丙酸乙酯 | Ethyl 3-(4-Methyl-2,5-dioxo-4-imidazolidinyl)propanoate | C9H14N2O4
| | |
25 | 1142202-22-9 | (5-(羟甲基)噁唑-2-基)氨基甲酸叔丁酯 | tert-Butyl [5-(hydroxymethyl)-1,3-oxazol-2-yl]-carbamate | C9H14N2O4
| | |
26 | 852934-04-4 | 4-(4,4-DIMETHYL-2,5-DIOXO-IMIDAZOLIDIN-1-YL)-BUTYRIC ACID | 4-(4,4-DIMETHYL-2,5-DIOXO-IMIDAZOLIDIN-1-YL)-BUTYRIC ACID | C9H14N2O4
| | |
27 | | 4-{[(cyclopropylmethyl)carbamoyl]amino}-4-oxobutanoic acid | 4-{[(cyclopropylmethyl)carbamoyl]amino}-4-oxobutanoic acid | C9H14N2O4
| | |
28 | 397847-48-2 | 2-Piperazineacetic acid, 5-(1-methylethyl)-3,6-dioxo- (9CI) | 2-Piperazineacetic acid, 5-(1-methylethyl)-3,6-dioxo- (9CI) | C9H14N2O4
| | |
29 | | methyl 3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propanoate | methyl 3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propanoate | C9H14N2O4
| | |
30 | | 3-(4-ethyl-4-methyl-2,5-dioxoimidazolidin-1-yl)propanoic acid | 3-(4-ethyl-4-methyl-2,5-dioxoimidazolidin-1-yl)propanoic acid | C9H14N2O4
| | |
31 | | 5-(2-methoxyethoxy)-1,3-dimethyl-1H-pyrazole-4-carboxylic acid | 5-(2-methoxyethoxy)-1,3-dimethyl-1H-pyrazole-4-carboxylic acid | C9H14N2O4
| | |
32 | 684206-85-7 | 4-Pyrimidinecarboxylicacid,5,5-diethylhexahydro-2,6-dioxo-(9CI) | 4-Pyrimidinecarboxylicacid,5,5-diethylhexahydro-2,6-dioxo-(9CI) | C9H14N2O4
| | |
33 | 740059-30-7 | 4-Isoxazolepropanoicacid,alpha-amino-3-ethoxy-5-methyl-,(R)-(9CI) | 4-Isoxazolepropanoicacid,alpha-amino-3-ethoxy-5-methyl-,(R)-(9CI) | C9H14N2O4
| | |
34 | 1975118-35-4 | 3-[(2-methoxyethoxy)methyl]-1-methyl-1H-pyrazole-4-carboxylic acid | 3-[(2-methoxyethoxy)methyl]-1-methyl-1H-pyrazole-4-carboxylic acid | C9H14N2O4
| | |
35 | | 4-amino-2-{[(2-methylcyclopropyl)carbonyl]amino}-4-oxobutanoic acid | 4-amino-2-{[(2-methylcyclopropyl)carbonyl]amino}-4-oxobutanoic acid | C9H14N2O4
| | |
36 | 1795751-79-9 | (R)-7-(2-methoxyacetyl)tetrahydro-1H-oxazolo[3,4-a]pyrazin-3(5H)-one | (R)-7-(2-methoxyacetyl)tetrahydro-1H-oxazolo[3,4-a]pyrazin-3(5H)-one | C9H14N2O4
| | |
37 | 785753-74-4 | 4-Isoxazoleaceticacid,alpha-amino-3-methoxy-5-methyl-,ethylester(9CI) | 4-Isoxazoleaceticacid,alpha-amino-3-methoxy-5-methyl-,ethylester(9CI) | C9H14N2O4
| | |
38 | 865792-22-9 | 5-Isoxazolepropanoic acid, -alpha--amino-2,3-dihydro-3-oxo-4-propyl- | 5-Isoxazolepropanoic acid, -alpha--amino-2,3-dihydro-3-oxo-4-propyl- | C9H14N2O4
| | |
39 | 583861-17-0 | Carbamic acid, (4,5-dihydro-5-methyl-4-oxo-2-oxazolyl)-, 1,1-dimethylethyl | Carbamic acid, (4,5-dihydro-5-methyl-4-oxo-2-oxazolyl)-, 1,1-dimethylethyl | C9H14N2O4
| | |
40 | 387338-22-9 | 2H-1,3-Oxazine-4-propanamide, tetrahydro-N,N-dimethyl-2,5-dioxo-, (4S)- (9CI) | 2H-1,3-Oxazine-4-propanamide, tetrahydro-N,N-dimethyl-2,5-dioxo-, (4S)- (9CI) | C9H14N2O4
| | |
41 | 865792-23-0 | 5-Isoxazolepropanoic acid, -alpha--amino-2,3-dihydro-4-(1-methylethyl)-3-oxo- | 5-Isoxazolepropanoic acid, -alpha--amino-2,3-dihydro-4-(1-methylethyl)-3-oxo- | C9H14N2O4
| | |
42 | 745014-72-6 | 1-Cyclohexene-1-carboxamide, 3-(dimethylamino)-2,5-dihydroxy-6-oxo-, (5R)- (9CI) | 1-Cyclohexene-1-carboxamide, 3-(dimethylamino)-2,5-dihydroxy-6-oxo-, (5R)- (9CI) | C9H14N2O4
| | |
43 | 130515-71-8 | | 2,4(1H,3H)-Pyrimidinedione, 1-[1-(2-hydroxy-1-methylethoxy)ethyl]-, [S-(R*,S*)]- (9CI) | C9H14N2O4
| | |
44 | 765308-97-2 | 2-Propynamide, N-[[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]methyl]- (9CI) | 2-Propynamide, N-[[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]methyl]- (9CI) | C9H14N2O4
| | |
45 | 644965-55-9 | Imidazo[1,2-a]pyridine-6,7,8-triol, 5,6,7,8-tetrahydro-5-(hydroxymethyl)-2-methyl-, (5R,6R,7S,8R)- (9CI) | Imidazo[1,2-a]pyridine-6,7,8-triol, 5,6,7,8-tetrahydro-5-(hydroxymethyl)-2-methyl-, (5R,6R,7S,8R)- (9CI) | C9H14N2O4
| | |